Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 22, 2026
Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV.
Journal: Open forum infectious diseases
Published: May 11, 2026
Inter- and intraindividual variability of long-acting injectable cabotegravir/rilpivirine trough concentrations after 1 year of continuous use.
Journal: The Journal of antimicrobial chemotherapy
Published: March 25, 2026
Letter: Low Uptake of HIV Pre-Exposure Prophylaxis Despite Pharmacist-Managed Services in a Midwestern Federally Qualified Health Center.
Journal: AIDS patient care and STDs
Published: March 10, 2026
Letter: A Longitudinal Model of HIV Clinical Pharmacy Service Expansion: A Decade-Plus Model of Clinical Expansion and Practice Integration.
Journal: AIDS patient care and STDs
Published: February 13, 2026
Engagement in Care and Sexually Transmitted Infection Screening Among Patients Prescribed Doxycycline Postexposure Prophylaxis at a Midwestern HIV/Preexposure Prophylaxis Clinic.
Journal: Open forum infectious diseases
Published: January 26, 2026
Real-World Impact of Insurance Changes on Long-acting Cabotegravir Plus Rilpivirine Delivery.
Journal: Open forum infectious diseases
Published: January 23, 2026
Kaposi Sarcoma-Associated Immune Reconstitution Inflammatory Syndrome (KS-IRIS) in Advanced HIV: Challenges in Managing Visceral Disease With Pericardial Involvement.
Journal: Open forum infectious diseases
Published: January 19, 2026
Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program.
Journal: Open forum infectious diseases
Published: December 08, 2025
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.
Journal: Therapeutic advances in musculoskeletal disease
Published: August 06, 2025
Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series.
Journal: Open forum infectious diseases
Published: July 24, 2025
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE.
Journal: The lancet. HIV
Published: July 01, 2025
Last Updated: 09/26/2026